1.
Characteristics of all PICO and VASCO participants included in this study a .
Fig 2 -
Fig 3 -
Fig 4 -
Fig 5 -
Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).
2.
3.
Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...
Characteristics of patients with intermediate thickness cutaneous melanoma (1.2–3.5 mm) on trunk or limb (n = 1989) diagnosed 2000–2016 in the Southern Netherlands.
Hazard Ratios (HR) of patients with intermediate-thickness (1.2–3.5 mm) melanoma diagnosed 2010–2016, followed-up until February 2021.
Studies on melanoma comparing outcome of SLNB and excision versus Obs (observation) after excision only.
